Vascular Diseases Biorepository

Overview

About this study

The eventual goal of this study is to identify genetic and proteomic markers that may influence susceptibility to vascular diseases including peripheral arterial disease, pulmonary hypertension, carotid artery stenosis, arterial aneurysmal disease, fibromuscular dysplasia, congenital heart disease and other less common diseases that affect the blood vessels.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with vascular diseases (pulmonary hypertension, peripheral arterial disease, carotid artery stenosis, arterial aneurysmal disease, fibromuscular dysplasia, and less common diseases that affect the blood vessels)

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Iftikhar Kullo, M.D.

Closed for enrollment

Contact information:

Dawn Shelstad

(507) 255-0473

shelstad.dawn@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20314157

Mayo Clinic Footer